Will This Upgrade Have A Positive Affect On Vitamin Shoppe (VSI) Stock On Wednesday?

NEW YORK (TheStreet) -- Vitamin Shoppe Inc. (VSI) was upgraded to "neutral" from "underperform" at Bank of America (BAC) Merrill Lynch on Wednesday.

The firm said it raised its rating on the marketer and retailer of vitamins, minerals, specialty supplements, sports nutrition, and other health products, as it believes the worst of the company's margin pressure is in the past.

Must ReadWarren Buffett's 25 Favorite Stocks 

Separately, TheStreet Ratings team rates VITAMIN SHOPPE INC as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:

"We rate VITAMIN SHOPPE INC (VSI) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

If you liked this article you might like

The Retail Apocalypse Is About to Descend on Wall Street This Coming Week

With the Latest Drinks on Tap, 5 Ways to Stay Cool on Sizzling Days